Publish in this journal
Journal Information
Vol. 57. Issue 1.
Pages 5-6 (January 2021)
Download PDF
More article options
Vol. 57. Issue 1.
Pages 5-6 (January 2021)
DOI: 10.1016/j.arbr.2020.03.023
Pharmacotherapy Impacts on COPD Mortality
La farmacoterapia tiene impacto en la mortalidad de la EPOC
Bartolome Cellia,
Corresponding author

Corresponding author.
, Miguel Divoa, Victor Pinto Platab
a Brigham and Women's Hospital, Harvard Medical School, Boston, USA
b Bay State Medical Center, University of Massachusetts Medical School, Springfield, USA
Article information
Full Text
Download PDF
Tables (1)
Table 1. Summary of Results of Randomized Trials of Different Inhaled Therapies Where All-cause Mortality Was Either the Primary or a Secondary Outcome. Only the Primary Comparisons Are Shown for Those Studies Where There Were More Than 2 Arms.


These are the options to access the full texts of the publication Archivos de Bronconeumología (English Edition)
If you are a member of SEPAR:
  • Go to >>>SEPAR<<< website and sign in.

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe to

Archivos de Bronconeumología (English Edition)

Comprar acceso al artículo

Comprando el artículo el PDF del mismo podrá ser descargado

Precio 19,34 €

Comprar ahora
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
Archivos de Bronconeumología (English Edition)

Subscribe to our newsletter

Article options
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.